首页> 美国卫生研究院文献>Journal of Virology >Gibbon Ape Leukemia Virus Receptor Functions of Type III Phosphate Transporters from CHOK1 Cells Are Disrupted by Two Distinct Mechanisms
【2h】

Gibbon Ape Leukemia Virus Receptor Functions of Type III Phosphate Transporters from CHOK1 Cells Are Disrupted by Two Distinct Mechanisms

机译:来自CHOK1细胞的III型磷酸转运蛋白的长臂猿猿猴白血病病毒受体功能受到两种不同机制的破坏。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The Chinese hamster cell lines E36 and CHOK1 dramatically differ in susceptibility to amphotropic murine leukemia virus (A-MuLV) and gibbon ape leukemia virus (GALV); E36 cells are highly susceptible to both viruses, CHOK1 cells are not. We have previously shown that GALV can infect E36 cells by using both its own receptor, HaPit1, and the A-MuLV receptor, HaPit2. Given that the two cell lines are from the same species, the loss of function of both of these receptors in CHOK1 cells is surprising. Other studies have shown that CHOK1 cells secrete proteins that block A-MuLV entry into CHOK1 as well as E36, suggesting the two A-MuLV receptors are functionally identical. However, CHOK1 conditioned medium does not block GALV entry into E36, indicating the secreted inhibitors do not block HaPit1. HaPit1 and ChoPit1 therefore differ as receptors for GALV; ChoPit1 is either inactivated by secreted factors or intrinsically nonfunctional. To determine why GALV cannot infect CHOK1, we cloned and sequenced ChoPit1 and ChoPit2. ChoPit2 is almost identical to HaPit2, which explains why CHOK1 conditioned medium blocks A-MuLV entry via both receptors. Although ChoPit1 and HaPit1 are 91% identical, a notable difference is at position 550 in the fourth extracellular region, shown by several studies to be crucial for GALV infection. Pit1 and HaPit1 have aspartate at 550, whereas ChoPit1 has threonine at this position. We assessed the significance of this difference for GALV infection by replacing the aspartate 550 in Pit1 with threonine. This single substitution rendered Pit1 nonfunctional for GALV and suggests that threonine at 550 inactivates ChoPit1 as a GALV receptor. Whether native ChoPit1 functions for GALV was determined by interference assays using Lec8, a glycosylation-deficient derivative of CHOK1 that is susceptible to both viruses and that has the same receptors as CHOK1. Unlike with E36, GALV and A-MuLV exhibited reciprocal interference when infecting Lec8, suggesting that they use the same receptor. We conclude both viruses can use ChoPit2 in the absence of the inhibitors secreted by CHOK1 and ChoPit1 is nonfunctional.
机译:中国仓鼠细胞株E36和CHOK1在对两性鼠白血病病毒(A-MuLV)和长臂猿猿猴白血病病毒(GALV)的敏感性上差异很大。 E36细胞对两种病毒都高度敏感,而CHOK1细胞则不然。先前我们已经证明GALV可以通过使用其自身的受体HaPit1和A-MuLV受体HaPit2感染E36细胞。假设这两个细胞系来自同一物种,则在CHOK1细胞中这两个受体的功能丧失令人惊讶。其他研究表明,CHOK1细胞分泌的蛋白质会阻止A-MuLV进入CHOK1以及E36,这表明这两个A-MuLV受体在功能上是相同的。但是,CHOK1条件培养基不会阻止GALV进入E36,这表明分泌的抑制剂不会阻止HaPit1。因此,HaPit1和ChoPit1作为GALV的受体不同。 ChoPit1被分泌因子失活或本质上无功能。为了确定GALV为什么不能感染CHOK1,我们克隆并测序了ChoPit1和ChoPit2。 ChoPit2与HaPit2几乎相同,这说明了为什么CHOK1条件培养基会阻止A-MuLV通过两个受体进入。尽管ChoPit1和HaPit1具有91%的同一性,但第四个细胞外区域中的550位是一个显着差异,一些研究表明这对GALV感染至关重要。 Pit1和HaPit1在550处具有天冬氨酸,而ChoPit1在此位置具有苏氨酸。我们通过用苏氨酸替代Pit1中的天冬氨酸550,评估了这一差异对GALV感染的重要性。这种单取代使Pit1对GALV失去功能,并表明550的苏氨酸可将ChoPit1失活为GALV受体。天然的ChoPit1是否对GALV起作用,是通过使用Lec8进行干扰分析确定的,Lec8是CHOK1的糖基化缺陷型衍生物,对两种病毒均敏感,并且与CHOK1的受体相同。与E36不同,GALV和A-MuLV在感染Lec8时表现出相互干扰,表明它们使用相同的受体。我们得出结论,两种病毒都可以在没有CHOK1分泌的抑制剂的情况下使用ChoPit2,并且ChoPit1是无功能的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号